Prevalence and predictors of suicidality among adults initiating office-based buprenorphine.
Authors
Lent MR, Dugosh KL, Hurstak E, Callahan HR, Mazur K
Abstract
Individuals who have substance use disorders may have an elevated risk of suicidality. This study sought to examine the prevalence of, and identify factors associated with, suicidality in adults with opioid use disorder (OUD) initiating office-based buprenorphine treatment.
